Company intelligence / Profile preview

Liberty Technologies

Worcester, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Liberty BioSecurity is a life sciences company focused on developing breakthrough pharmaceuticals and biological capabilities derived from extremophile species. As a subsidiary of EdenRoc Sciences, the company leverages molecular biology and artificial intelligence to identify novel compounds for healthcare, industrial, and government applications. Its primary research areas include infectious diseases, forensics, and biodefense, with a notable focus on lysin polypeptides active against Gram-negative pathogens. The company also spun off Delavie Sciences, which commercializes biological isolates for advanced skincare and UV protection.

Therapeutic areas: DermatologyInfectious Diseases
Modalities: PeptidesBiologicSmall molecule
Industry: Biotech

Partnerships

NASAU.S. Department of Defense

Beyond the preview

Go deeper on Liberty Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Liberty Technologies.

Explore the full profile